| HOUSE AMENDMENT |
| Bill No. HB 63B |
|
|
|
|
|
1
|
CHAMBER ACTION |
|
2
|
|
|
3
|
. |
|
4
|
. |
|
5
|
. |
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
Representative Ambler offered the following: |
|
13
|
|
|
14
|
Amendment |
|
15
|
Remove line(s) 2411-2413, and insert: |
|
16
|
(d)1. As a statewide goal of reducing the occurrence of |
|
17
|
medication error, inventory hospitals to determine the current |
|
18
|
status of implementation of computerized physician medication |
|
19
|
ordering systems, barcode point of care systems, or other |
|
20
|
technological patient safety implementation, and recommend a |
|
21
|
plan for expediting implementation statewide or, in hospitals |
|
22
|
where the agency determines that implementation of such systems |
|
23
|
is not practicable, alternative methods to reduce medication |
|
24
|
errors. The agency shall identify in its plan any barriers to |
|
25
|
statewide implementation and shall include recommendations to |
|
26
|
the Legislature of statutory changes that may be necessary to |
|
27
|
eliminate those barriers. The agency will review newly developed |
|
28
|
plans for compliance with statewide initiatives and to determine |
|
29
|
both the commitment of the health care facility staff and the |
|
30
|
capability of the facility to successfully coordinate and |
|
31
|
implement these plans, especially from a technological |
|
32
|
perspective.
|
|
33
|
2. “Medication error” is any preventable event that may |
|
34
|
cause or lead to inappropriate medication use or patient harm |
|
35
|
while the medication is in the control of the health care |
|
36
|
professional, patient, or consumer. Such events may be related |
|
37
|
to professional practice, health care products, health care |
|
38
|
procedures, and health care systems, each of which may include |
|
39
|
the prescribing of medications and order communications; product |
|
40
|
labeling; product packaging; the nomenclature, compounding, |
|
41
|
dispensing, distribution, administration, and use of |
|
42
|
medications; and education and monitoring related thereto.
|
|
43
|
|
|
44
|
|